Global Silk Route Research Alliance
全球丝绸之路研究联盟
Independent Think Tank · Geopolitics · Belt & Road · Eurasia
6 pieces in this archive
By Prof. Engr. Zamir Ahmed Awan
This photo shows an automatic intelligent intravenous drug compounding robot system at the Tongzhou branch of Beijing Anzhen Hospital in Beijing, capital of China, Feb. 3, 2026. (Xinhua/Li Xin) Do you remember sitting in…
By Prof. Engr. Zamir Ahmed Awan
Pakistan has invited Chinese companies to invest in the country and jointly innovate, manufacture and grow together, as both sides looked to deepen cooperation in pharmaceuticals and healthcare. Special Assistant to the Prime Minister…
By Prof. Engr. Zamir Ahmed Awan
Pakistan’s listed pharmaceutical sector delivered a record-breaking financial performance in 2025, with profits surging 78 percent year-on-year to Rs42.2 billion, driven by robust sales growth, easing input costs, and lower financial charges. The report,…
By Prof. Engr. Zamir Ahmed Awan
Data shows medical, veterinary instruments, and appliances remain the largest export category Pakistan's exports of medical, surgical, and precision instruments to China exceeded $11.41 million in 2025, reflecting steady expansion in higher-value manufacturing segments,…
By Prof. Engr. Zamir Ahmed Awan
Policy envisages regulated plant cultivation, derivatives manufacturing for medicinal and industrial use The federal cabinet has approved the National Cannabis Control and Regulatory Policy, 2025, to curb the misuse of cannabis and market manipulation.…
By Prof. Engr. Zamir Ahmed Awan
Pakistan’s pharmaceutical industry has set an ambitious target of achieving USD 10 billion in exports. The development came during a meeting between Federal Minister for Finance and Revenue, Senator Muhammad Aurangzeb, and a high-level…
